Drug Profile
Aspirin/clopidogrel - Teva Pharmaceutical Industries
Alternative Names: Clopidogrel/aspirin - Teva Pharmaceutical IndustriesLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class 2 ring heterocyclic compounds; Antiplatelets; Antipyretics; Chlorobenzenes; Esters; Pyridines; Salicylic acids; Small molecules; Thienopyridines
- Mechanism of Action Cyclooxygenase inhibitors; Platelet ADP receptor antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Acute coronary syndromes
Most Recent Events
- 24 Jan 2019 Aspirin/clopidogrel is not yet available for Acute coronary syndromes in Eropean Union, Iceland, Liechtenstein and Norway (PO)